US Broker Ratings

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Biotechnology Innovator with 90% Upside Potential

Dyne Therapeutics, Inc. (DYN), a rising player in the biotechnology sector, has captured the attention of investors with a compelling potential upside of 90.36%. As a..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A Biotech with 134% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands out in the biotechnology sector with a compelling growth narrative and significant potential upside for investors. Specializing in developing therapeutic..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a 36.71% Upside in the Biopharmaceutical Sector

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is capturing the attention of investors with its promising growth potential in the biopharmaceutical sector. With a market capitalization of $2.99..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 34% Upside Potential in a Transformative Medical Device Market

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands out in the healthcare sector as a dynamic player in the medical devices industry, focusing on innovative technology solutions..

Envista Holdings Corporation (NVST) Stock Analysis: Exploring Potential Upside with a Strong Revenue Growth

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, presents an intriguing opportunity for investors...

CONMED Corporation (CNMD) Stock Report: Exploring a 22.87% Potential Upside in the Medical Device Sector

CONMED Corporation (NASDAQ: CNMD), a prominent player in the medical devices industry, has captured investor attention with a projected potential upside of 22.87%. This potential, combined..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a Potential 18.84% Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the healthcare sector as a formidable player within the medical instruments and supplies industry. Established in 1983 and..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Strong Buy with a 17.34% Upside Potential

Shares of Alphatec Holdings, Inc. (NASDAQ: ATEC), which operates in the dynamic healthcare sector focusing on medical devices, have been generating buzz among investors. With a..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Unraveling a Potential 79.7% Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a pioneering name in the medical devices segment of the healthcare sector, has been drawing significant attention from investors due to..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Powerhouse with Strong Revenue Growth and Analyst Confidence

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a noteworthy player in the biotechnology sector, not just for its innovative portfolio but also for its impressive financial..

Amicus Therapeutics, Inc. (FOLD): Investor Outlook with a 75% Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD) has positioned itself as a formidable player in the biotechnology sector, focusing on the development of novel treatments for rare diseases...

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Healthcare Opportunities with a 5.32% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, operates an extensive network of senior living communities across the United States. Specializing..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: 27.44% Potential Upside Beckons Investors

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector, particularly within the niche of Medicare Advantage plans. Based in Orange, California, this company..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges in the Healthcare Sector

BGM Group Ltd. (BGM), a key player in China’s healthcare landscape, operates primarily within the specialty and generic drug manufacturing industry. Despite a promising market cap..

Adaptive Biotechnologies Corpor (ADPT) Stock Analysis: Unpacking a 26.25% Potential Upside Amidst Robust Revenue Growth

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering player in the biotechnology sector, is making waves with its groundbreaking immune medicine platform. Headquartered in Seattle, Washington, this..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A Strong Buy with 21.69% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is attracting significant interest from investors and analysts alike with its innovative approach to drug development in the biotechnology sector. The..

Clover Health Investments (CLOV) Stock Analysis: Unlocking a 24.36% Upside Potential in Healthcare

Clover Health Investments, Corp. (NASDAQ: CLOV) is making waves in the healthcare sector, particularly within the healthcare plans industry. With its innovative approach to Medicare Advantage..

Bausch Health Companies Inc. (BHC) Investor Outlook: Analyzing Growth Potential and Strategic Positioning

Investors eyeing the healthcare sector might find Bausch Health Companies Inc. (NYSE: BHC) an intriguing proposition. With a market cap of $2.37 billion, this Canadian specialty..

Vericel Corporation (VCEL) Investor Outlook: Analyzing a Potential 39.6% Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL) is capturing the attention of investors in the biotechnology sector with its promising potential upside of 39.6%, based on its recent analyst..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech with a Potential 185% Upside

Janux Therapeutics, Inc. (NASDAQ: JANX) is capturing the attention of investors with its promising potential upside of 185.06%, according to recent analyst ratings. This San Diego-based..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds